Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Deckert

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
Oncogene|July 8, 2009
The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expressionA D Baudot, P Y Jeandel, X Mouska, et al.
Oncogene|June 21, 2011
SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survivalN Fenouille, A Puissant, M Tichet, et al.
The Journal of Experimental Medicine|August 10, 2000
Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reactionH Babbe, A Roers, A Waisman, et al.
Acta Neuropathologica|November 9, 2001
Human herpes virus-8 is not associated with primary central nervous system lymphoma in HIV-negative patientsM Montesinos-Rongen, V H Hans, A M Eis-Hübinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylationB Mollereau, M Deckert, O Déas, et al.
Oncogene|September 28, 2005
A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysisA Jacquel, M Herrant, V Defamie, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 20, 2001
Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot studyU Schlegel, H Pels, A Glasmacher, et al.
Cell Death and Differentiation|July 3, 2010
Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growthT Botton, A Puissant, Y Cheli, et al.
International Journal of Cancer|July 18, 2000
Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenograftsP M Deckert, A Jungbluth, N Montalto, et al.
Leukemia|June 5, 2009
Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphomaH Schwindt, I Vater, M Kreuz, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Oncogene|July 8, 2009
The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expressionA D Baudot, P Y Jeandel, X Mouska, et al.
Oncogene|June 21, 2011
SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survivalN Fenouille, A Puissant, M Tichet, et al.
The Journal of Experimental Medicine|August 10, 2000
Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reactionH Babbe, A Roers, A Waisman, et al.
Acta Neuropathologica|November 9, 2001
Human herpes virus-8 is not associated with primary central nervous system lymphoma in HIV-negative patientsM Montesinos-Rongen, V H Hans, A M Eis-Hübinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylationB Mollereau, M Deckert, O Déas, et al.
Oncogene|September 28, 2005
A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysisA Jacquel, M Herrant, V Defamie, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 20, 2001
Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot studyU Schlegel, H Pels, A Glasmacher, et al.
Cell Death and Differentiation|July 3, 2010
Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growthT Botton, A Puissant, Y Cheli, et al.
International Journal of Cancer|July 18, 2000
Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenograftsP M Deckert, A Jungbluth, N Montalto, et al.
Leukemia|June 5, 2009
Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphomaH Schwindt, I Vater, M Kreuz, et al.
Pageof 15